Healthcare companies require flexible strategies and innovative business models. They face continual reforms and regulations, with consequent pressures on their income, costs, and access to capital.

We have extensive experience in valuations of the health sector at an international level. We also work with the most important pharmaceutical companies in the world, both in physical asset management, as in the valuation of patents for compliance with USGAAP and IFRS standards.